Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivaracetam Dose-Ranging in Refractory Partial Onset Seizures
NCT00175825Phase 2Completed
- Sponsor
- UCB
- Start
- Nov 2005
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 2, randomised, double-blind trial of brivaracetam in focal epilepsy (4 arms), sponsored by UCB. Primary endpoint: Partial Onset Seizure Frequency Per Week During the 7-week Treatment Period. Started Nov 2005; status: completed.
02
Drugs
brivaracetam
03
Conditions
focal epilepsy
Beyond the preview
Go deeper on NCT00175825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00175825.